Oliver Pötz

1.2k total citations
37 papers, 883 citations indexed

About

Oliver Pötz is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Oliver Pötz has authored 37 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Oliver Pötz's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Oliver Pötz is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Carcinogens and Genotoxicity Assessment (5 papers). Oliver Pötz collaborates with scholars based in Germany, Denmark and United States. Oliver Pötz's co-authors include Thomas Joos, Markus F. Templin, Stefan Krämer, Jochen M. Schwenk, Dieter Stoll, Helen Hammer, Albert Braeuning, Felix F. Schmidt, Philip Marx‐Stoelting and Peter Seizer and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Oliver Pötz

35 papers receiving 865 citations

Peers

Oliver Pötz
Comparison fields: 5 of 105
  • Molecular Biology 486
  • Hematology 139
  • Oncology 113
  • Biomedical Engineering 101
  • Radiology, Nuclear Medicine and Imaging 90
Fen Wang China
Jianshi Yu United States
Junxian Lim Australia
Giampaolo Minetti Italy
Min Qiu China
Yiping Jia United States
Yoko Nagai Japan
Jan Österreicher Czechia
Yuki Niwa Japan
Jinghua Wang China
Fen Wang China View profile →
Citations per field, relative to Oliver Pötz
Oliver Pötz · 1×
Citations per year, relative to Oliver Pötz
Oliver Pötz · 1×

Countries citing papers authored by Oliver Pötz

Since Specialization
Citations

This map shows the geographic impact of Oliver Pötz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Pötz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Pötz more than expected).

Fields of papers citing papers by Oliver Pötz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Pötz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Pötz. The network helps show where Oliver Pötz may publish in the future.

Co-authorship network of co-authors of Oliver Pötz

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Pötz. A scholar is included among the top collaborators of Oliver Pötz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Pötz. Oliver Pötz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients Frontiers in Immunology Martín W. Bauer, Stephan Stenglein et al. 0
2 Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats Toxicologic Pathology Kateřina Vlasáková, Sean P. Troth et al. 2
3 Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3 Biomedicine & Pharmacotherapy Maitane Asensio, Óscar Briz et al. 0
4 Dicloxacillin is an inducer of intestinal P‐glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users British Journal of Clinical Pharmacology Martin Ernst, Patrick C. Souverein et al. 1
5 Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons Neuropharmacology Helen Hammer, Flemming Nielsen et al. 2
6 Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes Clinical Pharmacology & Therapeutics Flemming Nielsen, Kim Brøsen et al. 7
7 Pesticide mixture effects on liver protein abundance in HepaRG cells Toxicology Felix F. Schmidt, Dajana Lichtenstein et al. 8
8 An eight-compound mixture but not corresponding concentrations of individual chemicals induces triglyceride accumulation in human liver cells Toxicology Dajana Lichtenstein, Jimmy Alarcan et al. 5
9 Cross-species analysis of hepatic cytochrome P450 and transport protein expression Archives of Toxicology Helen Hammer, Felix F. Schmidt et al. 69
10 Representing dynamic biological networks with multi-scale probabilistic models Communications Biology Alexander Groß, Barbara Kracher et al. 20
11 Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR/hPXR mice Archives of Toxicology Philip Marx‐Stoelting, Constanze Knebel et al. 43
12 A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib EBioMedicine Tobias Sinnberg, Ana Velić et al. 40
13 Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells Nature Communications Henning Kempf, Ruth Olmer et al. 91
14 Systematic reference sample generation for multiplexed serological assays Scientific Reports Hannes Planatscher, Gerd Michel et al. 13
15 Release of Matrix Metalloproteinase-8 During Physiological Trafficking and Induced Mobilization of Human Hematopoietic Stem Cells Stem Cells and Development Mike Essl, Stefan Stevanović et al. 21
16 Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia BMC Cancer Evgeny A. Moskalev, Ivan A. Vorobjev et al. 40
17 Snapshots of Protein Dynamics and Post-translational Modifications In One Experiment—β-Catenin and Its Functions Molecular & Cellular Proteomics Peter K. Sorger, Andreas Hecht et al. 20
18 Receptor Tyrosine Kinase Inhibitor Profiling Using Bead-Based Multiplex Sandwich Immunoassays Methods in molecular biology Oliver Pötz, Nicole Schneiderhan‐Marra et al. 4
19 Protein–protein‐interactions in a multiplexed, miniaturized format a functional analysis of Rho GTPase activation and inhibition PROTEOMICS Michael Schmohl, Oliver Pötz et al. 6
20 Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome Thrombosis and Haemostasis Boris Bigalke, Konstantinos Stellos et al. 35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026